David M Boruta, MD
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
Present Title & Affiliation
Primary Appointment
Co-Chair, Education Pillar, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Department Representative, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Interests
Dr. David Boruta is a Professor in the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. He earned his medical degree from The University of Michigan and completed his residency training in obstetrics and gynecology at Brigham and Women’s and Massachusetts General Hospitals in Boston. He completed his gynecologic oncology fellowship at The University of North Carolina at Chapel Hill in 2003. Dr. Boruta relocated to Houston in 2019 and previously held academic appointments with Harvard Medical School, Tufts University Medical School, and the Medical College of Wisconsin.
Dr. Boruta’s clinical and research expertise focuses on the development and incorporation of minimally invasive surgical techniques in women with gynecologic cancers. He has authored and co-authored numerous publications in high-impact peer reviewed journals. In addition to his academic and teaching roles at MD Anderson Cancer Center, he takes great pride in delivering excellent patient care in the community setting.
Education & Training
Degree-Granting Education
| 1996 | University of Michigan, Ann Arbor, Michigan, US, MD |
| 1992 | University of Michigan, Ann Arbor, Michigan, US, Science, BA |
Postgraduate Training
| 2000-2003 | Fellowship, Gynecologic Oncology, University of North Carolina, Chapel Hill, North Carolina |
| 1996-2000 | Residency, Obstetrics and Gynecology, Brigham and Women's Hospital and Massachusetts General Hospital, Boston, Massachusetts |
Licenses & Certifications
| 2019 | Texas Medical Board License |
| 2009 | New Hampshire Board of Medicine Medical License |
| 2008 | Commonwealth of Massachusetts Board of Registration in Medicine, Medical License |
| 2006 | American Board of Obstetrics and Gynecology Certification in Gynecology Oncology |
| 2005 | American Board of Obstetrics and Gynecology Certification in Obstetrics and Gynecology |
| 2003 | State of Wisconsin Medical Examining Board |
| 2000 | North Carolina Medical Board |
Experience & Service
Extramural Institutional Committee Activities
Member, Value Analysis Team, The University of Texas MD Anderson Cancer Center, 2024 - Present
Co-Chair, Colon and Rectal Surgery Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Education Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Operating Room Steering Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Editorial Activities
Associate Editor, The Journal of Minimally Invasive Gynecology, 2018 - Present
Editorial Board Member, The Journal of Minimally Invasive Gynecology, 2018 - 2019
Editorial Board Member, Gynecologic Oncology Reports, 2018
Honors & Awards
| 2025 | National Patient Experience Recognition Award for 2023 - Top 1%, Consumer Assessment of Healthcare Providers and Systems |
| 2023 | National Patient Experience Recognition Award for 2023 - Top 1%, Consumer Assessment of Healthcare Providers and Systems |
| 2022 | Annual APGO Excellence in Teaching Award for 2022, Association of Professors of Gynecologic Oncology, Crofton, Maryland |
| 2022 | National Patient Experience Recognition Award for 2022 - Top 1%, Consumer Assessment of Healthcare Providers and Systems |
| 2021 | National Patient Experience Recognition Award for 2021 - Top 1%, Consumer Assessment of Healthcare Providers and Systems |
| 2021 | UT Kendra Scott Women's Entrepreneurial Leadership Institute's Female Founder Pitch Competition, First Prize, 2021, UT MD Anderson Cancer Center, Houston, Texas |
| 2019 | Excellence in Teaching Award, Tufts University Medical School |
| 2018 | Outstanding Faculty Teaching Award, Tufts University Medical School |
| 2017 - 2018 | Boston Top Doctor, Boston Magazine |
| 2014 | International Development and Education Award Mentor, American Society of Clinical Oncology |
| 2012 | Best Video Abstract, Oncology, AAGL Annual Meeting |
| 2012 | Partners in Excellence Team Award, Partners Healthcare |
| 2010 | Grand Haven High School Hall of Fame, Grand Haven Schools Foundation |
| 2008 | Obstetrics and Gynecology Resident Teaching Award, American College of Obstetricians and Gynecologists Council on Resident Education |
| 2002 | Fellows Award for Teaching Excellence, University of North Carolina, Department of Obstetrics and Gynecology |
| 2001 | Gynecologic Oncology Fellows' Forum Advisor, Glaxo Smith Kline |
| 2000 | Molecular Biology in Clinical Oncology Workshop Scholar, American Association of Cancer Research |
| 1999 | Outstanding Teacher of Obstetrics and Gynecology, Harvard Medical School |
| 1996 | Highest Distinction Graduate, University of Michigan Medical School |
| 1995 | Alpha Omega Alpha, University of Michigan Medical School |
| 1992 | James B. Angell Scholar, University of Michigan |
| 1992 | Magna cum laude graduate, University of Michigan |
| 1991 | Phi Beta Kappa, University of Michigan |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Texas Biodesign: A novel cross industry and university system collaboration to foster and stimulate convergent healthcare innovation. Poster. UT Austin and MD Anderson Collaborative Research Summit. Austin, TX,. Austin, Texas, US.
Formal Peers
- 2018. Surpassing the standard of care: uterine cancer within Steward. Invited. Boston, MA, US.
- 2018. Can cutting help cure? The role of surgery in ovarian cancer care. Invited. Boston, MA, US.
- 2018. Uterine cancer: review and updates for clinicians. Invited. Methuen, MA, US.
- 2018. Uterine cancer: what every woman needs to know. Invited. Methuen, MA, US.
- 2017. Sentinel lymph node mapping in endometrial cancer staging. Invited. Boston, MA, US.
- 2017. LESS means more: single-site laparoscopy. Invited. Boston, MA, US.
- 2016. A 30-Year-Old Woman with Severe Lower Abdominal Pain and Chills, NEJM Clinicopathological Conference. Invited. Boston, MA, US.
- 2015. Sentinel lymph node mapping for endometrial cancer: an update. Invited. Boston, MA, US.
- 2015. TLH 101: avoiding the pitfalls, Topics in Contemporary Obstetrics and Gynecology. Invited. Boston, MA, US.
- 2015. LESS Means More – Single Site Hysterectomy, Topics in Contemporary Obstetrics and Gynecology. Invited. Boston, MA, US.
- 2014. Laparoendoscopic single-site surgery made simple(r). Invited. Worchester, ME, US.
- 2014. Laparoendoscopic single-site surgery made simple(r). Invited. Burlington, VT, US.
- 2014. Laparoendoscopic single-site surgery made simple(r). Invited. Stonebridge, MA, US.
- 2014. Uterine leiomyosarcoma and impact of morcellation. Invited. Nashua, NH, US.
- 2014. Laparoendoscopic single-site surgery made simple(r). Invited. Boston, MA, US.
Grant & Contract Support
| Date: | 2020 - 2022 |
| Title: | Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE) Trial |
| Funding Source: | MDACC Institutional Research Grant |
| Role: | PI |
| Date: | 2020 - 2022 |
| Title: | Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE) Trial |
| Funding Source: | MDACC Institutional Research Grant |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Knisely A, Dai Y, Barlow GL, Lee S, Lawson B, Clark H, Fellman B, Yuan Y, Lu W, Lubo Julio IC, Lazcano RN, Chelvanambi M, Melendez B, Singh B, Singh B, Wani K, Chen J, Yeh CC, Gao J, Barnes S, Shi O, Khan KB, Serrano AG, Gomez-Bolanos LI, Scalise CB, Cheung SK, Dutta P, Velichko S, ElNaggar AC, Liu MC, Wilke RN, How J, Ramondetta LM, Boruta DM, Richardson G, Shafer A, Westin SN, Sims T, Sood AK, Ramirez PT, Lazar AJ, Soliman PT, Lu K, Haymaker CL, Solis Soto LM, Wargo JA, Grisham R, Wucherpfennig KW, Wang L, Jazaeri AA. Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunities. Clin Cancer Res 31(19):4122-4135, 2025. e-Pub 2025. PMID: 40748258.
- Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta DM, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC. Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol 42(10):JCO2300141, 2024. e-Pub 2024. PMID: 38194613.
- Abbott J, Boruta DM, Frishman GN, Kho R, Michels L, Setubal AM, Truong M. Farewell to Dr. Falcone. J Minim Invasive Gynecol 30(7):515-516, 2023. e-Pub 2023. PMID: 37423708.
- Nitecki R, Boruta DM. Innovation in Cancer Surgery: Maintaining Focus on Survival as the Critical Outcome. J Minim Invasive Gynecol 29(2):177-178, 2022. e-Pub 2021. PMID: 34954137.
- Sims TT, Boruta DM. Sentinel lymph node isolated tumor cells in early staged endometrioid endometrial cancer: Utility or futility?. Gynecol Oncol 161(2):331-332, 2021. e-Pub 2021. PMID: 33902864.
- Ryngajllo M, Boruta DM, Bizukojc M. Complete genome sequence of lovastatin producer Aspergillus terreus ATCC 20542 and evaluation of genomic diversity among A. terreus strains. Appl Microbiol Biotechnol 105(4):1615-1627, 2021. e-Pub 2021. PMID: 33515286.
- Boruta DM. Oh, Our Aching Backs: Attention to Ergonomics in MIGS Is Sorely Needed. J Minim Invasive Gynecol 27(5):983-984, 2020. e-Pub 2020. PMID: 32304864.
- Nitecki R, Diver EJ, Kamdar MM, Boruta DM, Del Carmen MC, Clark RM, Goodman A, Schorge JO, Growdon WB. Patterns of palliative care referral in ovarian cancer: A single institution 5?year retrospective analysis. Gynecol Oncol 148(3):521-526, 2018. e-Pub 2018. PMID: 29395315.
- Melamed A, Nitecki R, Boruta DM, Del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. Obstet Gynecol 129(5):861-869, 2017. e-Pub 2017. PMID: 28383367.
- Dorney KM, Growdon WB, Clemmer J, Rauh-Hain JA, Hall TR, Diver E, Boruta D, del Carmen MD, Goodman A, Schorge JO, Horowitz N, Clark RM. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgery for vulvar cancer. Gynecologic Oncology 144(1):136-139, 2017. e-Pub 2017. PMID: 27836203.
- Melamed A, Keating NL, Clemmer JT, Bregar AJ, Wright JD, Boruta DM, Schorge JO, Del Carmen MG, Rauh-Hain JA. Laparoscopic staging for apparent stage I epithelial ovarian cancer. Am J Obstet Gynecol 216(1):50.e1-50.e12, 2017. e-Pub 2017. PMID: 27567562.
- Simmons LH, Goldstein AJ, Boruta DM, Stall JN. Case 33-2016. A 30-Year-Old Woman with Severe Lower Abdominal Pain and Chills. N Engl J Med 375(17):1672-1681, 2016. e-Pub 2016. PMID: 27783909.
- Boruta DM, Shibley T. Power Morcellation of Unsuspected High-grade Leiomyosarcoma Within an Inflated Containment Bag: 2-year Follow-up. J Minim Invasive Gynecol 23(6):1009-11, 2016. e-Pub 2016. PMID: 27393286.
- Foley OW, Rauh-Hain JA, Clark RM, Goodman A, Growdon WB, Boruta DM, Schorge JO, Del Carmen MG. Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies. Am J Clin Oncol 39(4):329-34, 2016. e-Pub 2016. PMID: 24685883.
- Penson RT, Sales E, Sullivan L, Borger DR, Krasner CN, Goodman AK, del Carmen MG, Growdon WB, Schorge JO, Boruta DM, Castro CM, Dizon DS, Birrer MJ. A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecol Oncol 141(1):108-12, 2016. e-Pub 2016. PMID: 27016236.
- Rauh-Hain JA, Vargas RJ, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol 39(1):43-8, 2016. e-Pub 2016. PMID: 24390270.
- Boruta DM, Hall TR. Laparoendoscopic Single-Site Radical Parametrectomy for Treatment of Cervix Cancer Diagnosed After Simple Hysterectomy. J Minim Invasive Gynecol 22(6S):S121, 2015. e-Pub 2015. PMID: 27678640.
- Melamed A, Rauh-Hain JA, Clemmer JT, Diver EJ, Hall TR, Clark RM, Uppal S, Goodman A, Boruta DM. Changing Trends in Lymphadenectomy for Endometrioid Adenocarcinoma of the Endometrium. Obstet Gynecol 126(4):815-22, 2015. e-Pub 2015. PMID: 26348192.
- Rauh-Hain JA, Connor SC, Clemmer JT, Foley OW, Clark RM, Hall TR, Boruta DM, Schorge JO, del Carmen MG. Trends in Treatment of Uterine Serous Cancer in the Medicare Population. Int J Gynecol Cancer 25(6):1023-30, 2015. e-Pub 2015. PMID: 25914960.
- Joseph N, Clark RM, Dizon DS, Lee MS, Goodman A, Jr BD, Schorge JO, Del Carmen MG, Growdon WB. Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer. Gynecologic Oncology 137(3):401-405, 2015. e-Pub 2015. PMID: 25839911.
- Rauh-Hain JA, Hariton E, Clemmer J, Clark RM, Hall T, Boruta DM, Schorge JO, Del Carmen MG. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer. Obstet Gynecol 125(6):1362-70, 2015. e-Pub 2015. PMID: 26000507.
- Rauh-Hain JA Buskwolfe A, Clemmer J, Boruta DM, Schorge JO, del Carmn MG. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstetrics and Gynecology 125(4):843-851, 2015. e-Pub 2015. PMID: 25751197.
- Aviki EM, Rauh-Hain JA, Clark RM, Hall TR, Berkowitz LR, Boruta DM, Growdon WB, Schorge JO, Goodman A. Gynecologic Oncologist as surgical consultant: intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training. Gynecol Oncol 137(1):93-7, 2015. e-Pub 2015. PMID: 25617772.
- Fanfani F, Boruta DM, Fader AN, Vizza E, Growdon WB, Kushnir CL, Corrado G, Scambia G, Turco LC, Fagotti A. Feasibility and surgical outcome in obese versus nonobese patients undergoing laparoendoscopic single-site hysterectomy: a multicenter case-control study. J Minim Invasive Gynecol 22(3):456-61, 2015. e-Pub 2015. PMID: 25510981.
- Clark RM, Lee MS, Alejandro Rauh-Hain J, Hall T, Boruta DM, del Carmen MG, Goodman A, Schorge JO, Growdon WB. Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy. Gynecol Oncol 136(3):516-20, 2015. e-Pub 2015. PMID: 25475542.
- Fagotti A, Ghezzi F, Boruta DM, Scambia G, Escobar P, Fader AN, Malzoni M, Fanfani F. Minilaparoscopic radical hysterectomy (mLPS-RH) vs laparoendoscopic single-site radical hysterectomy (LESS-RH) in early stage cervical cancer: a multicenter retrospective study. J Minim Invasive Gynecol 21(6):1005-9, 2014. e-Pub 2014. PMID: 24768978.
- Rauh-Hain JA, Goodman A, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Endometrial stromal sarcoma: a clinicopathologic study of 29 patients. J Reprod Med 59(11-12):547-52, 2014. e-Pub 2014. PMID: 25552126.
- Cohen SL, Einarsson JI, Wang KC, Brown D, Boruta D, Scheib SA, Fader AN Shibley T. Contained Power Morcellation Within an Insufflated Isolation Bag. Obstetrics and Gynecology 124(3):491-497, 2014. e-Pub 2014. PMID: 25162248.
- Group SGO, Burke WM, Orr J Leitao M, Salom E, Gehrig P, Olawaiye AB, Brewer M, Boruta D, Herzog TJ, Shahin FA, Practice Committee SOGOC. Endometrial cancer: A comprehensive review and current management strategies, Part II. Gynecologic Oncology 134(2):393-402, 2014. e-Pub 2014. PMID: 24929052.
- Group SGO, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, Brewer M, Boruta D, Villella J, Herzog T, Abu Shahin F, Practice Committee SOGOC. Endometrial cancer: A comprehensive review and current management strategies, Part I. Gynecologic Oncology 134(2):385-392, 2014. e-Pub 2014. PMID: 24905773.
- Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, Schorge JO, Del Carmen MG, Horowitz NS, Boruta DM. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 133(2):216-20, 2014. e-Pub 2014. PMID: 24548726.
- Boruta DM, Fagotti A, Bradford LS, Escobar PF, Scambia G, Kushnir CL, Michener CM, Fader AN. Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer. J Minim Invasive Gynecol 21(3):394-8, 2014. e-Pub 2014. PMID: 24161887.
- Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Dizon DS, Schorge JO, del Carmen MG. Management and outcomes for elderly women with vulvar cancer over time. BJOG 121(6):719-27; discussion 727, 2014. e-Pub 2014. PMID: 24621118.
- Guseh SH, Rauh-Hain JA, Tambouret RH, Davis M, Clark RM, Boruta DM, Goodman A, Growdon WB, Schorge JO, del Carmen MG. Transitional cell carcinoma of the ovary: a case-control study. Gynecol Oncol 132(3):649-53, 2014. e-Pub 2014. PMID: 24462804.
- Rauh-Hain JA, Davis M, Clemmer J, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis. Gynecol Oncol 131(2):404-9, 2013. e-Pub 2013. PMID: 24004647.
- Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol 209(5):468.e1-468.e10, 2013. e-Pub 2013. PMID: 23891626.
- Garrett LA, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome. J Reprod Med 58(11-12):469-76, 2013. e-Pub 2013. PMID: 24568040.
- Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis. Gynecol Oncol 131(1):46-51, 2013. e-Pub 2013. PMID: 23906658.
- Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in cervical cancer survival over time. Cancer 119(20):3644-52, 2013. e-Pub 2013. PMID: 23913530.
- Scheib SA, Jones HH, Boruta DM, Simpson K, Bedaiwy M, Grumbine FC, Fader AN. Laparoendoscopic single-site surgery for management of adnexal masses in pregnancy: case series. J Minim Invasive Gynecol 20(5):701-7, 2013. e-Pub 2013. PMID: 24034540.
- Clark RM, Growdon WB, Wiechert A, Boruta D, Del Carmen M, Goodman AK, Bradford L, Rauh-Hain A, Schorge JO. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma. Gynecologic Oncology 130(3):407-410, 2013. e-Pub 2013. PMID: 23747329.
- Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M, Schorge J, Mueller P, Growdon W. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecologic Oncology 129(2):332-335, 2013. e-Pub 2013. PMID: 23402902.
- Boruta DM, Bradford LS. Laparoendoscopic single-site extraperitoneal paraaortic lymphadenectomy for endometrial cancer staging. Gynecol Oncol 128(1):132, 2013. e-Pub 2013. PMID: 30036926.
- Garrett LA, Boruta DM. Laparoendoscopic single-site radical hysterectomy: the first report of LESS type III hysterectomy involves a woman with cervical cancer. Am J Obstet Gynecol 207(6):518.e1-2, 2012. e-Pub 2012. PMID: 23111114.
- Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol 125(2):376-80, 2012. e-Pub 2012. PMID: 22366593.
- Fagotti A, Boruta DM, Scambia G, Fanfani F, Paglia A, Escobar PF. First 100 early endometrial cancer cases treated with laparoendoscopic single-site surgery: a multicentric retrospective study. Am J Obstet Gynecol 206(4):353.e1-6, 2012. e-Pub 2012. PMID: 22365037.
- Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM, Horowitz NS, del Carmen MG, Schorge JO. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Ann Surg Oncol 19(3):959-65, 2012. e-Pub 2012. PMID: 21994038.
- Growdon WB, Rauh-Hain JJ, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Int J Gynecol Cancer 22(3):417-24, 2012. e-Pub 2012. PMID: 22237383.
- Spencer R, Schorge J, Del Carmen M, Goodman A, Growdon W, Boruta D. Laparoscopic surgery for endometrial cancer: why don't all patients go home the day after surgery?. J Minim Invasive Gynecol 19(1):95-100, 2012. e-Pub 2012. PMID: 22196258.
- Boruta DM, Growdon WB, McCann CK, Garrett LA, del Carmen MG, Goodman A, Schorge JO. Evolution of surgical management of early-stage endometrial cancer. Am J Obstet Gynecol 205(6):565.e1-6, 2011. e-Pub 2011. PMID: 21855843.
- McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A. Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol 18(10):2912-8, 2011. e-Pub 2011. PMID: 21424880.
- Esselen KM, Boruta DM, del Carmen M, Schorge JO, Goodman A, Growdon WB. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review. Int J Gynecol Cancer 21(6):1078-83, 2011. e-Pub 2011. PMID: 21633304.
- Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol 121(3):477-81, 2011. e-Pub 2011. PMID: 21420726.
- Boruta DM, Growdon WB, Schorge JO. Single-incision laparoscopic staging for endometrial cancer. J Am Coll Surg 212(1):e1-5, 2011. e-Pub 2011. PMID: 21184954.
- Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecol Oncol 119(2):299-304, 2010. e-Pub 2010. PMID: 20691465.
- Skinner EN, Boruta DM, Gehrig PA, Boggess JF, Fowler WC, Van Le L. Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up. Gynecol Oncol 98(1):59-62, 2005. e-Pub 2005. PMID: 15913741.
- Boruta DM, Gehrig PA, Groben PA, Bae-Jump V, Boggess JF, Fowler WC, Van Le L. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?. Cancer 101(10):2214-21, 2004. e-Pub 2004. PMID: 15452833.
- Boruta DM, Fowler WC, Gehrig PA, Boggess JF, Walton LA, Van Le L. Weekly paclitaxel infusion as salvage therapy in ovarian cancer. Cancer Invest 21(5):675-81, 2003. e-Pub 2003. PMID: 14628424.
- Boruta DM, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 81(1):82-7, 2001. e-Pub 2001. PMID: 11277655.
Review Articles
- Boruta DM. Laparoendoscopic single-site surgery in gynecologic oncology: An update. Gynecol Oncol 141(3):616-623, 2016. e-Pub 2016. PMID: 26980644.
- Hall T, Lee SI, Boruta DM, Goodman A. Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery. Oncologist 20(11):1274-82, 2015. e-Pub 2015. PMID: 26382742.
- Davis M, Rauh-Hain JA, Andrade C, Boruta DM, Schorge JO, Horowitz NS, May T, del Carmen MG. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol 132(3):760-6, 2014. e-Pub 2014. PMID: 24440832.
- Bradford LS, Boruta DM. Laparoendoscopic single-site surgery in gynecology: a review of the literature, tools, and techniques. Obstet Gynecol Surv 68(4):295-304, 2013. e-Pub 2013. PMID: 23943039.
- Fader AN, Boruta D, Olawaiye AB, Gehrig PA. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol 22(1):21-9, 2010. e-Pub 2010. PMID: 19952744.
- Boruta DM, Gehrig PA, Fader AN, Olawaiye AB. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol 115(1):142-153, 2009. e-Pub 2009. PMID: 19592079.
- Olawaiye AB, Boruta DM. Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol 113(2):277-83, 2009. e-Pub 2009. PMID: 19251307.
Editorials
- Boruta DM, Farley J, Birrer MJ. Patients with recurrent ovarian cancer should be treated with antiangiogenic agents in combination with chemotherapy. Clinical Ovarian Cancer 2(1):12-23, 2009.
Abstracts
- Knisely A, Nitecki R, Fellman BM, Rauh-Hain JA, Hillman RT, Taylor JS, Ramondetta LM, Onstad, Cobb LP, Boruta DM, Richardson G, Soliman PT, Shafer A, Westin SN, Fleming ND, Sims TT, Sood AK, Ramirez PT, Lu KH, Jazaeri AA. Utility of surgically documented minimal residual disease as a therapeutic target and early surrogate of frontline treatment outcomes in ovarian cancer. Journal of Clinical Oncology 41(16_suppl. 5549):5549-5549, 2023.
- Knisely A, Nitecki R, Rauh-Hain JA, Hillman RT, Taylor JS, Ramondetta LM, Grinsfelder MO, Cobb LP, Boruta DM, Richardson G, Soliman PT. The utility of surgical minimal residual disease after frontline treatment for prognostic and investigational opportunities in advanced ovarian cancer. Cancer Research. Cancer Research.
- Nitecki R, Dang M, Sanghoon L, Fellman B, Rauh-Hain JA, Taylor J, Ramondetta L, Grinsfelder M, Cobb L, Boruta DM, Soliman PT, Shafer A, Fleming ND, Westin SN, Sood AK, Tanguma C, Ramirez PT, Lu KH, Wang L, Jazaeri AA. Initial clinicopathologic and molecular characterization of minimal residual disease detected by second look laparoscopy after completion of frontline surgery and chemotherapy in patients with advanced stage ovarian cancer. American Association for Cancer Research Annual Meeting 2022 AACR; Cancer Res 2022(82 (12_Suppl)).
- Alpard SK, Truskett VN, Bartlett R, Boruta DM, Jennings A, Price M, Romig K, Hunt KK, Lu K, Checka C. Texas Biodesign: A Novel Cross Industry and University System Collaboration to Foster Convergent Healthcare Innovation. ANNALS OF SURGICAL ONCOLOGY 2022 29(SUPPL 2):467-467.
- Knisely A, Sims T, Griffin D, Ramondetta L, Collins S, Cobb L, Boruta D, Richardson G, Sood A, Ramirez P, Lu K. RF2 Feasibility and preliminary results of the first clinical trial targeting minimal residual disease in patients with homologous recombination proficient (HRP) ovarian cancer. Gynecologic Oncology.
- Boruta D, Glassman D, Alpard S, Checka C, Bartlett R, VanTruskett V, Jennings A, Price M. Innovation in gynecologic oncology fellowship training: Rethinking the research year (1207). Gynecologic Oncology.
- Knisely A, Nitecki R, Dang M, Lee S, Fellman B, Rauh-Hain J, Hillman R, Taylor J, Ramondetta L, Grinsfelder M, Cobb L, Boruta D, Jazaeri A. Transforming frontline therapy in ovarian cancer by focusing on surgically documented minimal residual disease after frontline treatment (1178). Gynecologic Oncology.
- How JA, Rauh-Hain JA, Grinsfelder M, Rangel KM, Roder S, Shafer A, Schmeler KM, Boruta DM, Fleming ND, Lu KH, Vining DJ. Triage of advanced cervical cancer through immunotherapy induction (TRACTION). Journal of Clinical Oncology.
Book Chapters
- Boruta DM, Escobar PF. Laparoendoscopic single-site surgery in gynecologic oncology. In: Principles of Gynecologic Oncology Surgery. 1. Elsevier, 331-343, 2019.
- Diver E, Boruta DM. Laparoscopic staging of pelvic malignancies. In: Minimally Invasive Gynecologic Surgery: Evidence Based Laparoscopic, Hysteroscopic and Robotic Surgeries. 1. JP Medical Ltd, 221-228, 2016.
- Sisodia RM, Del Carmen MG, Boruta DM. Role of minimally invasive surgery in the management of adnexal masses. In: Clin Obstet Gynecol. 1, 66-75, 2015.
- Rauh-Hain JA, Olawaiye AB, Boruta DM. Uterine clear cell carcinoma. In: Uncommon Gynecologic Cancers. 1. Wiley, 186-194, 2015.
- Brown J, Boruta. Laparoscopic management of pelvic masses in pregnancy. In: Curr Obstet Gynecol Rep. 3, 270-276, 2014.
- Schorge JO, Boruta DM. Uterine Procedures. In: Gynecologic Oncology: Clinical Practice & Surgical Atlas. 1. McGraw-Hill, 493-530, 2012.
- Weber S, McCann CK, Boruta DM, Schorge JO, Growdon WB. Laparoscopic surgical staging of early ovarian cancer. In: Rev Obstet Gynecol. 3-4, 117-22, 2011.
- Del Carmen MG, Boruta DM, Schorge JO. Recurrent endometrial cancer. In: Clin Obstet Gynecol. 2, 266-77, 2011.
- Fader AN, Boruta D, Olawaiye AB, Gehrig PA. Uterine papillary serous carcinoma: epidemiology, pathogenesis, and management. In: Curr Opin Obstet Gynecol. 1, 21-29, 2010.
- Nickles Fader A, Boruta DM, Olawaiye AB, Gehrig PA. Update on uterine papillary serous cancer. In: Expert Rev Obstet Gynecol. 6, 647-657, 2009.
- Boruta DM, Le V. Ovarian tumors of low malignant potential: Current understanding and controversy. In: Curr Prob Obstet Gynecol Fertil. 2, 44-57, 2002.
Patient Reviews
CV information above last modified July 22, 2026